MANUFACTURING / PRODUCTION / PROCESS
Process manufacturing
6 markets · continuous-flow operations · yield optimization drives edge
AVG S1
11.9%
leader share
AVG CR3
26.0%
weighted 25.6%
AVG HHI
309
Unconcentrated
AVG REV/EMP
$1.3M
leader avg
AVG SG&A %
10%
of revenue (leader avg)
MARKETS
6
in category
Continuous-flow process industries — pharma, chemicals, refining, paper, plastics, glass. Concentration sits in the middle: more than discrete manufacturing, less than capital-intensive. Feedstock access, process efficiency, and regulatory approvals drive the edge. AI impact: moderate — primarily through yield optimization, predictive maintenance, and supply-chain orchestration rather than labor compression.
Markets ranked by S1 (click bar for calculation breakdown)
S1 vs CR3 structure map
Bottom-left = fragmented. Top-right = concentrated. Click dot for calculation →
Historical trends — key markets in Manufacturing / Production
5 representative markets. Solid = S1 (leader share), dashed = CR3 (top 3 share).
Metrics:Y-Axis:
Manufacturing / Production: Concentration Over Time
How concentrated is the average manufacturing / production market? Solid = CR3 (top 3 share), dotted = S1 (leader share).
Metrics:Y-Axis:
What this shows: The solid line is CR3 — the average combined market share of the top 3 companies across 6 manufacturing / production markets. The dotted line is S1 — the average share of the #1 company alone. Data spans 1960–2025. Markets included: Pharma / Biopharma, Specialty Chemicals, Petroleum Refining, Paper & Packaging, Plastics & Rubber, Glass Manufacturing.
All markets (6) — click any row for detail
MARKETLEADERS1CR3REV/EMPSG&ASIZE
Glass Manufacturing
Process · ~10 firms
O-I Glass
18.0%
40.0%
$220K
7%
$15B
Petroleum Refining
Process · ~25 firms
Marathon Petroleum
17.0%
42.0%
$4.8M
2%
$400B
Paper & Packaging
Process · ~500 (including 1,500+ small converters) firms
Smurfit Westrock
12.0%
22.5%
$480K
10%
$260B
Plastics & Rubber
Process · 1,000+ globally (highly fragmented; top players follow) firms
Amcor (incl. Berry)
11.0%
16.5%
$290K
9%
$120B
Pharma / Biopharma
Process · Hundreds globally; top-3 reflect 2024 GLP-1 transformation firms
Eli Lilly
8.5%
23.0%
$620K
26%
$600B
Specialty Chemicals
Process · 100+ firms
Dow
5.0%
12.0%
$1.1M
4%
$250B
Data vintage: FY 2024 / FY 2025 · Next refresh: Q3 2026 (mid-FY26 10-Ks)
Source Quality Hierarchy
Every market has a primary source plus 1–3 validation sources. Revenue numerators come from SEC 10-K filings; denominators validated against the Economic Census where available.
TIER 1Authoritative anchorsGovernment data + SEC filings
US Economic Census (data.census.gov) · SEC EDGAR / Company 10-Ks · BEA Industry Value-Added (FRED) · BLS QCEW · USGS Mineral Commodity Summaries · EIA Refinery Capacity Report · FDA device listings
TIER 2Leading commercial trackersIndustry-standard paid trackers
IDC Semiannual Software Tracker · Gartner Market Share & Magic Quadrant · IBISWorld NAICS reports · StatCounter Global Stats · eMarketer / Insider Intelligence · Synergy Research Group
TIER 3Category specialistsBest-in-class niche authorities
SIPRI (aerospace & defense) · IQVIA (pharma) · TrendForce (semiconductors) · CIMdata (CAD/PLM) · Nilson Report (payments) · Am Law 100 (legal) · ENR Top 500 (A&E) · AM Best (insurance) · SIA (staffing) · Ad Age (agencies) · Barron's / Cerulli (wealth) · Evaluate MedTech · Nielsen Gauge (streaming) · Gridwise (ride-hail) · Bloomberg Second Measure (delivery) · RC Top 100 (roofing) · SDM Top 100 (fire/safety) · Big 4 annual reports · ALM Intelligence (consulting)
Data vintage: Q2 2025 research compilation. Labels updated 2026-Q2. Tier 1 sources refreshed from FY2025 SEC filings where available. For full methodology see the Methodology page.